Structures by: Rida M.
Total: 7
(3<i>S</i>,4<i>S</i>)-4-Phenyl-1,5-bis(prop-2-en-1-yl)-3-(prop-2-en-1-yloxy)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C24H26N2O2
IUCrData (2016) 1, 7 x161175
a=9.6138(2)Å b=8.8891(2)Å c=11.7292(3)Å
α=90° β=97.1270(10)° γ=90°
(3<i>Z</i>)-3-Benzylidene-1<i>H</i>-benzimidazo[1,2-<i>a</i>]imidazol-2(3<i>H</i>)-one
C16H11N3O
IUCrData (2016) 1, 12 x161908
a=6.6849(3)Å b=8.9428(5)Å c=10.7445(5)Å
α=103.935(3)° β=95.015(4)° γ=96.860(3)°
3-Hydroxy-4-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C15H14N2O2
IUCrData (2016) 1, 11 x161879
a=5.519(2)Å b=21.594(8)Å c=9.917(4)Å
α=90° β=90.405(5)° γ=90°
(3<i>S</i>,4<i>S</i>)-1-Benzyl-3-hydroxy-4-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C22H20N2O2
IUCrData (2016) 1, 11 x161849
a=8.9169(2)Å b=17.6360(5)Å c=11.7937(3)Å
α=90° β=109.1990(10)° γ=90°
<i>rac</i>-(3<i>S</i>,4<i>S</i>)-3-Hydroxy-4-phenyl-1-[(<i>S</i>)-(3-phenyl- 4,5-dihydro-1,2-oxazol-5-yl)methyl]-4,5-dihydro-1<i>H</i>-1,5-benzodiazepin- 2(3<i>H</i>)-one
C25H23N3O3
Acta Crystallographica Section E (2011) 67, 4 o945-o946
a=8.981(2)Å b=9.044(2)Å c=13.6850(10)Å
α=95.373(10)° β=102.433(10)° γ=100.03(2)°
3-Hydroxy-4-phenyl-1-(prop-2-en-1-yl)-2,3,4,5-tetrahydro-1<i>H</i>- 1,5-benzodiazepin-2-one
C18H18N2O2
Acta Crystallographica Section E (2012) 68, 1 o238
a=51.6665(8)Å b=14.5766(2)Å c=11.9316(2)Å
α=90.00° β=90.965(2)° γ=90.00°
5-Acetyl-3-hydroxy-4-phenyl-4,5-dihydro-1<i>H</i>-1,5-benzodiazepin- 2(3<i>H</i>)-one
C17H16N2O3
Acta Crystallographica Section E (2011) 67, 12 o3337
a=8.97100(10)Å b=9.31420(10)Å c=9.41290(10)Å
α=81.5630(10)° β=68.9210(10)° γ=80.1460(10)°